BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30732953)

  • 1. Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness.
    Park W; Park J; Park SI; Kim H; Bae H; Cho J; Won H; Park M; Jeong HS
    Oral Oncol; 2019 Feb; 89():144-149. PubMed ID: 30732953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.
    Terakedis BE; Hunt JP; Buchmann LO; Avizonis VN; Anker CJ; Hitchcock YJ
    Am J Clin Oncol; 2017 Jun; 40(3):323-328. PubMed ID: 25503431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of facial nerve weakness on diagnosis of a parotid gland malignant process.
    Wierzbicka M; Kopeć T; Szyfter W; Kereiakes T; Bem G
    Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1177-82. PubMed ID: 22179671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult Temporal Bone Facial Nerve Involvement by Parotid Malignancies with Perineural Spread.
    Carlson ML; Patel NS; Modest MC; Moore EJ; Janus JR; Olsen KD
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):385-91. PubMed ID: 26129739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facial nerve function after parotidectomy.
    Bron LP; O'Brien CJ
    Arch Otolaryngol Head Neck Surg; 1997 Oct; 123(10):1091-6. PubMed ID: 9339986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of facial nerve sacrifice in parotidectomy for primary and metastatic malignancies.
    Swendseid B; Li S; Thuener J; Rezaee R; Lavertu P; Fowler N; Zender C
    Oral Oncol; 2017 Oct; 73():43-47. PubMed ID: 28939075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review of 300 cases of parotidectomy for benign parotid tumors].
    Kawata R; Lee K; Yoshimura K; Nishimawa S; Araki M
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Jun; 115(6):618-24. PubMed ID: 22844822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects and therapy of extratemporal facial neurinoma].
    Jaehne M; Ussmüller J
    HNO; 2001 Apr; 49(4):264-9. PubMed ID: 11382106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma.
    Mikoshiba T; Ozawa H; Watanabe Y; Kawaida M; Sekimizu M; Saito S; Yoshihama K; Nakamura S; Nagai R; Imanishi Y; Kameyama K; Ogawa K
    Laryngoscope; 2022 Jan; 132(1):96-102. PubMed ID: 34245171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial nerve preservation in total parotidectomy for parotid tumors: a review of 27 cases.
    El-Shakhs S; Khalil Y; Abdou AG
    Ear Nose Throat J; 2013 Jun; 92(6):E1. PubMed ID: 23780595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parotid Gland Tumors and the Facial Nerve.
    Gandolfi MM; Slattery W
    Otolaryngol Clin North Am; 2016 Apr; 49(2):425-34. PubMed ID: 27040587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotidectomy in the treatment of aggressive cutaneous malignancies.
    Lai SY; Weinstein GS; Chalian AA; Rosenthal DI; Weber RS
    Arch Otolaryngol Head Neck Surg; 2002 May; 128(5):521-6. PubMed ID: 12003582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perineural Invasion in Parotid Gland Malignancies.
    Huyett P; Duvvuri U; Ferris RL; Johnson JT; Schaitkin BM; Kim S
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1035-1041. PubMed ID: 29337642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of postoperative facial weakness in parotid tumor surgery: a tumor subsite analysis of 794 parotidectomies.
    Jin H; Kim BY; Kim H; Lee E; Park W; Choi S; Chung MK; Son YI; Baek CH; Jeong HS
    BMC Surg; 2019 Dec; 19(1):199. PubMed ID: 31878919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra-parotid neurofibroma of the facial nerve].
    Jund R; Nerlich A; Hagedorn H; Issing WJ
    Laryngorhinootologie; 1998 Dec; 77(12):719-22. PubMed ID: 10036676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent benign pleomorphic adenoma of the parotid gland: Facial nerve identification and risk factors for facial nerve paralysis at re-operation.
    Kuriyama T; Kawata R; Higashino M; Nishikawa S; Inui T; Terada T; Haginomori SI; Kurisu Y; Hirose Y
    Auris Nasus Larynx; 2019 Oct; 46(5):779-784. PubMed ID: 30922530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of supramaximal stimulation to predict facial nerve outcomes following vestibular schwannoma microsurgery: results from a decade of experience.
    Schmitt WR; Daube JR; Carlson ML; Mandrekar JN; Beatty CW; Neff BA; Driscoll CL; Link MJ
    J Neurosurg; 2013 Jan; 118(1):206-12. PubMed ID: 23140153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neglected giant parotid gland mass: excision and reconstruction with facial nerve preservation.
    Pamuk AE; Cabbarzade C; Uner H; Günaydın RÖ; Kosemehmetoglu K
    Otolaryngol Pol; 2014; 68(6):333-7. PubMed ID: 25441940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratifying the risk of facial nerve palsy after benign parotid surgery.
    Sethi N; Tay PH; Scally A; Sood S
    J Laryngol Otol; 2014 Feb; 128(2):159-62. PubMed ID: 24461039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Facial nerve monitoring in parotid gland surgery].
    Wang Z; Wu H; Huang Q; Cao R; Chen X; Yang J; Xiang M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(10):436-7. PubMed ID: 16883785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.